Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): A phase-II randomized clinical trial

ABSTRACT: Background: Highly active antiretroviral therapy produces a significant decrease in HIV-1 replication and allows an increase in the CD4 T-cell count, leading to a decrease in the incidence of opportunistic infections and mortality. However, the cost, side effects and complexity of antiretr...

Full description

Autores:

Montoya Guarín, Carlos Julio
Jaimes Barragán, Fabián Alberto
Higuita David, Edwin Andrés
Convers Páez, Sandra Milena
Estrada Mesa, Santiago
Gutiérrez Henao, Francisco Javier
Giraldo Álzate, Newar Andrés
Amariles Muñoz, Pedro
Peñalosa, Cristina
Rugeles López, María Teresa

Tipo de recurso:

Article of investigation

Fecha de publicación:

2009

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/36727

Acceso en línea:

https://hdl.handle.net/10495/36727

Palabra clave:

Anticolesterolemiantes
Anticholesteremic Agents
Terapia Antirretroviral Altamente Activa
Antiretroviral Therapy, Highly Active
Antivirales
Antiviral Agents
Infecciones por VIH
HIV Infections
Lovastatina
Lovastatin
Análisis de Regresión
Regression Analysis
Ensayo Clínico
Clinical Trial

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/